JMI Laboratories advances antimicrobial therapies worldwide through outstanding science. Our GLP and reference quality microbiology and molecular services support the development of bacterial and fungal antimicrobial agents. Our expert team is here for you, whether your drug needs spectrum of activity testing, diagnostics development, or quality control parameters established or requires services aligned with its position in a phase I-IV clinical trial; new drug application, or post-approval safety monitoring period. We can chart the epidemiology of resistance mechanisms, fully describe resistance and virulence genes, and provide molecular typing for referred isolates. Our global surveillance antimicrobial monitoring program (SENTRY), along with our Microbiology Visualization Platform (MVP) software application, allows surveillance users, including participating hospital labs and sponsors, to view and query surveillance data to see susceptibility and resistance trends over time. Furthermore, we can work with your team to create publications that showcase the in vitro activity of your therapeutic to an appropriate audience.